... about Document Destruction A former Pfizer employee claims that Pfizer colleagues destroyed documents related to a federal investigation of Celebrex and Bextra. The employee recently testified about these events before a federal grand jury in Boston. This is his story, edited for ... I was asked to. Being naive, I agreed to let Pfizer provide me with my legal counsel (apparently, the Pfizer lawyers could not represent me, but they informed me that my lawer would be -----------and that he would ...
April 10, 2009 05:12 am
... 's improper behavior caused false claims to be submitted to federal health-care programs for reimbursement. In addition to the marketing allegations, government lawyers allege that Forest lavished doctors with cash payments, expensive meals and other valuables to induce them to prescribe the ... that Johnson & Johnson illegally marketed its heart drug Natrecor. In January, Pfizer said it would pay $2.3 billion to settle charges that it illegally promoted Bextra, a painkiller now off the market.
February 26, 2009 09:06 am
... to False Claims fraud plus $5,500 to $11,000 for every fraudulent claim filed. This most recent move by DOJ is just one in a number of lawsuits against prescription drug companies for off-label Medicare fraud that includes Pfizer's Bextra, GlaxoSmithKline's off-label marketing and promotions of various of its products, and Medtronic's off-label promotion of various of its productions. If you are interested in learning more about federal or Tennessee False Claims Law, check out the Higgins Firm's ...
February 23, 2009 06:10 pm
... pass such an insane law. My good friend and fellow trial lawyer, Jay Cook, wrote an op-ed column in the Atlanta Journal and Constitution ... lure more businesses to Georgia and "protect Georgia companies from personal injury lawyers." But who will protect consumers from pharmaceutical companies that care more about profits than people? ... If we need evidence (beyond Vioxx, Rezulin, fen-phen and Bextra) of the disastrous consequences of allowing industries to neuter their own government watchdogs, we ...
February 3, 2009 11:54 am
... ., the world's biggest drugmaker, must pay a research center $38.7 million for stealing data compiled by the foundation on its Bextra pain-killer drug, a California jury determined. State court jurors in San Jose yesterday found that Pfizer stole the ... 20 years has collected data on post-surgery medications, reactions, and placebo effects, said Pat Harris, an IREF lawyer. Pfizer said its conduct was "proper" and it will appeal the verdict. Source: Bloomberg.com: News Does it seem right that if a ...
December 24, 2008 11:44 am

LAW.COM Newswire Highlights December 24, 2008

(New York Supreme Court Criminal Term Library Blog)
... her activities after the accident but challenged the verdict on the basis of proximate cause. The Latest From the Ashes of Lehman The American Lawyer Monday was a pretty smooth day in the history of the Lehman Brothers bankruptcy. First, the big news: A federal bankruptcy judge ... a $38 million verdict against Pfizer on Monday for stealing trade secrets in an effort to keep its controversial drug Bextra on the market. The verdict ended a suit brought more than five years ago by the founder of the ...
December 24, 2008 08:12 am
... also claims that Pfizer and Hsu destroyed evidence when confronted about the data theft, said Mark Geragos, one of the foundation's lawyers. "They hired Hsu on the pretext of his expertise, but it was all bull," Geragos said. "They just wanted access to ( ... I had felt that Pfizer had stolen the information we had gathered in order to manipulate it to keep their drug Bextra on the market. They were willing to profit at the expense of patient safety, something I have fought against my whole life."
December 24, 2008 03:48 am
... injury lawsuits. Approximately $60 million will be used to settle claims brought by 33 states and the District of Columbia alleging that Bextra was inappropriately marketed. Another $89 million will be used to settled consumer fraud cases. My law firm currently represents Bextra and Celebrex victims and their families in lawsuits. The lawyers of The Lowe Law Firm are experienced in helping people injured by defective and dangerous drugs. We will ...
October 22, 2008 05:37 pm

Stories We're Following

(Legal Broadcast Network Blog)
(WSJ) Pfizer Inc. has agreed in principle to pay $894 million to settle litigation related to its painkillers Celebrex and Bextra. The bulk of the settlement, $745 million, will resolve 90% of the known personal injury suits that allege the painkillers caused heart ... pre-tax charge to earnings of $894 million, a statement provided by the company said. Next Week: Cleveland Immigration Lawyer David Leopold returns to discuss recent raids and a new immigration bill Robert Baer "The Devil We Know... ...
October 17, 2008 07:18 pm
... on April 11, 2007, I predicted that Pfizer would pay . . $400 million to settle Bextra/Celebrex. Today Pfizer announced they would pay $894 million. According ... state court judges overseeing a majority of the personal injury cases ruled that the plaintiffs' lawyers failed to present reliable scientific evidence to prove Celebrex can cause heart ... than Celebrex but a more skillful handling of this case by Pfizer. After all, Bextra was also taken off the market, just like Vioxx. Pfizer clearly has a ...
October 17, 2008 12:26 pm
... Do you remember such FDA fiasco's with the approval of Digitek (digoxin), the Ortho Evra Patch, Fosamax (alendronate), Bextra (valdecoxib)...? All are medicines initially approved by the FDA and then later serious problems arose...even recalls.... ... previously approved then recalled devices goes on and on and on.... So, the Wall Street Journal believes the trial lawyers in America are wrong for lobbying Congress to pass a law to hold manufacturers of previously FDA approved medicines and devices ...
August 14, 2008 10:51 am

Tuckered Out

(Drug and Device Law)
... ve said over and over again, we publish this blog from the perspective of defense lawyers in product liability litigation. We're in litigation - not regulatory. That means (among ... preemption view is a "180-degree reversal." What Kessler/Vladek doesn't mention is that the Bextra/Celebrex court (like Horn) deferred to the FDA anyway. Drilling down further, ... (which is why it probably hasn't been - we're not administrative lawyers, so we can't say for sure). In 2000, the FDA specifically requested, ...
July 31, 2008 05:30 pm

No Injury Scorecard

(Drug and Device Law)
... , Inc., 2006 WL 5574742 (Cal. Super. June 19, 2006). Having lawyer spend money to buy product on plaintiff's behalf held insufficient injury under ... risk of defibrillator failure is sufficient injury. The case applied California law. In re Bextra & Celebrex Marketing, Sales Practices & Product Liability Litigation, 2007 WL ... . July 10, 2007). Consumer fraud claims that plaintiffs purchased higher priced Bextra and Celebrex over available lower priced alternatives allege sufficient injury. ...
July 3, 2008 07:26 pm
Pfizer Inc on Wednesday named Amy Schulman, who has led litigation efforts for the drugmaker involving its painkillers Celebrex and Bextra, as its new general counsel. The WSJ wrote back in 2006, "At the ripe age of 45, she is the highest paid partner at ... you have to honor that rhythm. People get anxious when they feel they're going to be interrupted. What a good lawyer brings to a problem, in addition to creative solutions, is a quality of attentiveness. You can't listen with half an ear. The ...
May 28, 2008 04:37 am
... GC. The WSJ's Nathan Koppel has the story. Schulman, who in addition to defending Pfizer against lawsuits over Celebrex and Bextra, has rep'd GE and Altria Group, among other companies, and made a pretty penny doing it. Last ... . Pfizer didn't say what her pay would be. Schulman will report to Pfizer chairman and CEO Jeffrey Kindler (also a lawyer), who says of his new consigliere: "Her knowledge of the legal, business and regulatory challenges facing the pharmaceutical industry and her experience ...
May 27, 2008 06:02 am
... Wall Street Journal, firms have been offered $40,000 to $50,000 a client to resolve Celebrex cases and as much as $200,000 a client for Bextra. Despite the drugs apparent risk, Celebrex continued to generate $2.3 billion in sales in 2007, a 12 percent increase from the previous year. According to a report in Friday's Wall Street Journal, lawyers representing Pfizer have indicated the company is willing to pay as much as $500 million to resolve all outstanding cases.
May 9, 2008 04:23 pm
... to begin, Pfizer has struck tentative settlements with some plaintiffs who alleged that painkillers Celebrex and Bextra caused heart attacks, according to lawyers at three plaintiff firms involved in the litigation. Here's the breaking story from the ... 000 to $50,000 a client to resolve Celebrex suits (on the market). Attorneys representing Pfizer, according to two lawyers, have indicated the company is willing to pay as much $500 million overall to resolve the litigation. There are thousands of ...
May 1, 2008 03:03 pm
Drug maker giant, Pfizer, the maker of Celebrex and Bextra, have already reached settlements with hundreds of claimants and plaintiffs who maintain that the defective drugs caused them to ... has been actively trying to settle the defective drug lawsuits involving Celebrex and Bextra and has set aside a half a billion dollars to do so. Vioxx maker ... to trial. If you or a loved one has been injured or killed by Celebrex, Bextra, Vioxx any other defective drug, I would invite you to please visit my ...
April 30, 2008 04:08 pm
... in 2004 after it was linked to heart attacks and sudden cardiac deaths. Another COX-2 inhibitor, Bextra, was also pulled from the market. The lawyers of The Lowe Law Firm are experienced in helping people injured by a dangerous prescription drug. We will seek compensation for past ... initial consultation for victims of dangerous medications. If you cannot make it to our office, we will come to you at the hospital or your home. Contact the lawyers at The Lowe Law Firm today by calling 877-678-3400.
April 2, 2008 10:01 am

Today's News

(Drug and Device Law)
... 's Wall Street Journal reports on Pfizer's unsuccessful (at least before a magistrate judge) effort to subpoena documents about Bextra and Celebrex in the possession of the Journal of the American Medical Association. (HT to FDLI's SmartBrief.) Second, today's New ... American has this article about the widespread use of antidepressants. We express no opinion about the merits of the article, but it's out there in the popular press, so many pharmaceutical defense lawyers will be interested in it.
March 25, 2008 03:56 am
 
 

This Domain Owned by Justia.com - Inquire About Justia.com's Legal Marketing Services